Siga Technologies (SIGA) Total Liabilities (2010 - 2025)
Siga Technologies' (SIGA) quarterly Total Liabilities came in at $20.6 million in Q4 2025, down 27.64% on a YoY basis from $28.5 million in Q4 2024, and down 26.59% quarter-over-quarter from $28.1 million in Q3 2025.
Analysis
Siga Technologies (SIGA) Total Liabilities (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Total Liabilities for 16 consecutive years, with $20.6 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Total Liabilities fell 27.64% year-over-year to $20.6 million; the trailing twelve-month figure through Dec 2025 stood at $20.6 million (down 27.64% YoY), and the FY2025 full-year result was $20.6 million, down 27.64% from the prior year.
- Total Liabilities eased to $20.6 million in Q4 2025 per SIGA's latest filing, from $28.1 million in the prior quarter.
- Across five years, Total Liabilities topped out at $78.2 million in Q1 2024 and bottomed at $16.1 million in Q1 2021.
- Historically, Total Liabilities has averaged $29.7 million across 5 years, with a median of $26.0 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Total Liabilities soared 258.0% in 2024, then slumped 60.42% in 2025.
- Over 5 years, Total Liabilities stood at $40.4 million in 2021, then slumped by 38.44% to $24.9 million in 2022, then soared by 131.12% to $57.5 million in 2023, then plunged by 50.37% to $28.5 million in 2024, then retreated by 27.64% to $20.6 million in 2025.
- According to Business Quant data, Total Liabilities over the past three periods registered $20.6 million, $28.1 million, and $26.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 116.09 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 141.05 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 23.74 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 80.09 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 115.64 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 69.15 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 1.72 Bn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 1.53 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 819.80 Mn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - | 20.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 20.65 Mn |
| Sep 30, 2025 | 28.12 Mn |
| Jun 30, 2025 | 26.02 Mn |
| Mar 31, 2025 | 30.93 Mn |
| Dec 31, 2024 | 28.53 Mn |
| Sep 30, 2024 | 25.91 Mn |
| Jun 30, 2024 | 25.10 Mn |
| Mar 31, 2024 | 78.16 Mn |
| Dec 31, 2023 | 57.49 Mn |
| Sep 30, 2023 | 34.24 Mn |
| Jun 30, 2023 | 22.44 Mn |
| Mar 31, 2023 | 21.83 Mn |
| Dec 31, 2022 | 24.88 Mn |
| Sep 30, 2022 | 31.09 Mn |
| Jun 30, 2022 | 20.17 Mn |
| Mar 31, 2022 | 16.81 Mn |
| Dec 31, 2021 | 40.41 Mn |
| Sep 30, 2021 | 29.01 Mn |
| Jun 30, 2021 | 16.97 Mn |
| Mar 31, 2021 | 16.08 Mn |